When Flatliners Meet the Wearable Cardioverter-Defibrillator

Leadless pacemakers (LP) were introduced into clinical practice in 2016 when the Micra LP received FDA approval. Since then, more than 150,000 Micra have been implanted worldwide. In April 2022, the AVEIR LP was FDA approved. Implantation of these LPs requires a special set of skills that is different than the skill set required for implantation of traditional pacemakers. In this hands-on manuscript we detail the steps required for LP implantation while focusing on mitigating major complications.